Integral Diagnostics Ltd (IDX.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2020 | 06-2019 | 06-2018 | 06-2017 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -25,876 | -18,131 | -10,434 | -11,550 | -16,922 |
| Net Acquisitions | -66,891 | -76,841 | N/A | -3,529 | N/A |
| Other Investing Activity | -766 | 0 | 0 | 370 | 263 |
| Investing Cash Flow | $-93,533 | $-94,972 | $-10,434 | $-14,709 | $-16,659 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 34,317 | 131,056 | 4,641 | 10,887 | 17,043 |
| Debt Repayment | -2,654 | -57,029 | -12,209 | -8,134 | -31,134 |
| Common Stock Issued | 73,484 | 1,585 | N/A | N/A | 33,170 |
| Common Stock Repurchased | -3,509 | N/A | N/A | N/A | N/A |
| Dividend Paid | -18,029 | -14,025 | -11,603 | -10,154 | N/A |
| Other Financing Activity | -8,209 | -52 | -278 | -30 | -12,451 |
| Financing Cash Flow | $75,400 | $61,535 | $-19,449 | $-7,431 | $6,628 |
| Exchange Rate Effect | 881 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 20,967 | 20,844 | 24,210 | 23,620 | 9,596 |
| End Cash Position | 57,965 | 20,967 | 20,844 | 24,210 | 23,620 |
| Net Cash Flow | $36,117 | $486 | $-3,366 | $590 | $14,024 |
| Free Cash Flow | |||||
| Capital Expenditure | -25,876 | -18,669 | -11,578 | -11,650 | -17,222 |
| Free Cash Flow | -25,876 | -18,669 | -11,578 | -11,650 | -17,222 |